Verdinexor
Verdinexor (KPT-335) is an orally bioavailable, selective inhibitor of the nuclear export protein XPO1/CRM1. It is utilized in preclinical research to study oncology, virology, and inflammation, demonstrating activity in both cellular assays and animal models of cancer and viral infection.
Product Specifications
CAS Number
1392136-43-4
Product Name Alternative
CRM1, KPT335, KPT-335, KPT 335, Verdinexor
Field of Research
Cell Biology, Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:82 mg/mL (185.39 mM) ; Ethanol:9 mg/mL (20.35 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.46 mM)
Smiles
FC (F) (F) c1cc (cc (c1) C (F) (F) F) -c1ncn (\C=C/C (=O) NNc2ccccn2) n1
Molecular Formula
C18H12F6N6O
Molecular Weight
442.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
49767124 3x 1.0µg DNA
Vmn2r26 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 